NASDAQ:DCGO DocGo (DCGO) Stock Price, News & Analysis $1.72 +0.12 (+7.50%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.72 0.00 (0.00%) As of 08/22/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About DocGo Stock (NASDAQ:DCGO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DocGo alerts:Sign Up Key Stats Today's Range$1.59▼$1.7250-Day Range$1.33▼$1.7352-Week Range$1.23▼$5.68Volume498,507 shsAverage Volume534,622 shsMarket Capitalization$168.23 millionP/E RatioN/ADividend YieldN/APrice Target$3.59Consensus RatingModerate Buy Company Overview DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York. Read More DocGo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks42nd Percentile Overall ScoreDCGO MarketRank™: DocGo scored higher than 42% of companies evaluated by MarketBeat, and ranked 657th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingDocGo has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageDocGo has only been the subject of 1 research reports in the past 90 days.Read more about DocGo's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-68.00% Earnings GrowthEarnings for DocGo are expected to decrease by -68.00% in the coming year, from $0.25 to $0.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is -9.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is -9.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDocGo has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about DocGo's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.48% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in DocGo has recently decreased by 11.43%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.48% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in DocGo has recently decreased by 11.43%, indicating that investor sentiment is improving significantly. News and Social Media1.8 / 5News Sentiment0.19 News SentimentDocGo has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for DocGo this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for DCGO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.80% of the stock of DocGo is held by insiders.Percentage Held by Institutions56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DocGo's insider trading history. Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Email Address DCGO Stock News HeadlinesAnalysts Offer Insights on Healthcare Companies: Tyra Bioscience (TYRA) and DocGo (DCGO)August 23 at 4:03 AM | theglobeandmail.comDocGo price target raised to $1.60 from $1.45 at CanaccordAugust 21 at 10:39 PM | msn.comHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.August 23 at 2:00 AM | The Oxford Club (Ad)DocGo Announces Participation at Three Upcoming ConferencesAugust 18, 2025 | finance.yahoo.comDocGo Announces Participation at Three Upcoming ConferencesAugust 18, 2025 | businesswire.comWhat is Northland Capmk's Estimate for DocGo Q3 Earnings?August 15, 2025 | americanbankingnews.comWhat is Northland Capmk's Estimate for DocGo Q2 Earnings?August 14, 2025 | americanbankingnews.comDocGo, Inc. Earnings Call: A Mixed Bag of Progress and ChallengesAugust 13, 2025 | msn.comSee More Headlines DCGO Stock Analysis - Frequently Asked Questions How have DCGO shares performed this year? DocGo's stock was trading at $4.24 at the beginning of the year. Since then, DCGO shares have decreased by 59.4% and is now trading at $1.72. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) issued its quarterly earnings results on Thursday, August, 7th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.05. The firm earned $80.42 million during the quarter, compared to the consensus estimate of $77.58 million. DocGo had a negative trailing twelve-month return on equity of 3.26% and a negative net margin of 4.20%. Read the conference call transcript. Who are DocGo's major shareholders? Top institutional shareholders of DocGo include P.A.W. Capital Corp (3.14%), S Squared Technology LLC (2.82%), Geode Capital Management LLC (2.11%) and Jefferies Financial Group Inc. (2.10%). Insiders that own company stock include Lee Bienstock, Adriaan Stephanus Oberholzer, James M Travers, Anthony Capone, Stephen Sugrue, Ely D Tendler and Stephen K MD Klasko. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DocGo own? Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings8/07/2025Today8/23/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:DCGO CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees4,407Year FoundedN/APrice Target and Rating Average Price Target for DocGo$3.59 High Price Target$5.50 Low Price Target$1.60 Potential Upside/Downside+108.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.19) Trailing P/E RatioN/A Forward P/E Ratio6.88 P/E GrowthN/ANet Income$19.99 million Net Margins-4.20% Pretax Margin-6.94% Return on Equity-3.26% Return on Assets-2.24% Debt Debt-to-Equity RatioN/A Current Ratio2.36 Quick Ratio2.36 Sales & Book Value Annual Sales$616.55 million Price / Sales0.27 Cash Flow$0.46 per share Price / Cash Flow3.78 Book Value$2.94 per share Price / Book0.59Miscellaneous Outstanding Shares97,810,000Free Float94,091,000Market Cap$168.23 million OptionableOptionable Beta0.96 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:DCGO) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.